GLEEVEC vs IMKELDI
Independent side-by-side comparison.
Rating
70/100
New
Pharmacy pays
~$25.80 /30
~$25.80 /30
Type
RX
RX
Active ingredient
IMATINIB MESYLATE
IMATINIB MESYLATE
Manufacturer
Dosage forms
Tablet
Solution
Drug class
Kinase Inhibitor
Kinase Inhibitor
Boxed warning
None
None
Treats
Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome
Lymphoid Leukemia, Myeloid Leukemia, Hypereosinophilic Syndrome
Frequently asked questions
Which is cheaper, Gleevec or Imkeldi?
Pharmacies pay about the same to acquire either one — roughly $25.80 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Gleevec and Imkeldi?
Both Gleevec and Imkeldi share the active ingredient Imatinib Mesylate.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.